cache/3f737bfbfff3d5909be13403b99251f98751b69c3dba31e94ea4f777fdc2a3b5

COM:AVTTX

Ashvattha Therapeutics

  • Privately Held

Description

Ashvattha Therapeutics is a clinical-stage biotech company focused on developing novel dendrimer-based therapies to treat unmet medical needs in inflammatory, oncology, and ocular diseases. The company is advancing a new class of nanomedicine therapeutics that traverse tissue barriers to selectively target activated cells in regions of inflammation.

invested in